RXI PHARMACEUTICALS CORP NEW - 74979C303

Sector: No information yet · Industry: No information yet
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q1 2014 · Q4 2013
Value (USD)
Total reported value ($000)
$6.948M
QoQ value delta ($000)
+$6.948M
Shares
Total shares
1,628,045
QoQ shares delta
+1,628,044 (+162804400.0%)
Total shares held by funds (by quarter)

Top holders (Q1 2014)

Top 25 only Full list
Early Q2 2014 data: only 6 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Broadfin Capital, LLC 4,810 1,126,482 0.47%
Numeric Investors LLC 1,399 327,687 0.02%
JANE STREET GROUP, LLC 165 38,677 0.0%
GEODE CAPITAL MANAGEMENT, LLC 107 25,171 0.0%
Spark Investment Management LLC 107 25,300 0.02%
TANG CAPITAL MANAGEMENT LLC 78 18,245 0.04%
MORGAN STANLEY 72 16,786 0.0%
NORTHERN TRUST CORP 66 15,560 0.0%
CITADEL ADVISORS LLC 53 12,498 0.08%
GOLDMAN SACHS GROUP INC 45 10,454 0.0%
UBS AG 21 5,000 0.0%
Tower Research Capital LLC 18 4,327 0.0%
BARCLAYS PLC 4 1,100 0.0%
LADENBURG THALMANN FINANCIAL SERVICES INC 2 376 0.0%
CITIGROUP INC 1 157 0.0%
AMERICAN INTERNATIONAL GROUP INC 0 11 0.0%
WELLS FARGO & COMPANY/MN 0 5 0.0%
DIMENSIONAL FUND ADVISORS LP 0 61 0.0%
AMERIPRISE FINANCIAL INC 0 12 0.0%
GROUP ONE TRADING, L.P. 0 100 0.0%
ROYAL BANK OF CANADA 0 36 0.0%